Skip to main content
SpringerLink
Log in

Safety of atorvastatin 80 mg/day assessed in meta-analysis

  • Review
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The trials included healthy volunteers, patients with coronary artery disease, dyslipidaemia, atrial fibrillation, atherosclerotic vascular disease or stroke.

Reference

  • Li H, et al. Safety Profile of Atorvastatin 80 mg: A Meta-Analysis of 17 Randomized Controlled Trials in 21,910 Participants. Drug Safety : [11 pages], 10 Feb 2016. Available from: URL: http://dx.doi.org/10.1007/s40264-016-0394-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Safety of atorvastatin 80 mg/day assessed in meta-analysis. Reactions Weekly 1590, 11 (2016). https://doi.org/10.1007/s40278-016-15063-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-016-15063-4

Search

Navigation